RBC Capital analyst Brian Abrahams reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and maintains $55 price target.
- Headlines
- RBC Capital Reiterates Outperform on Xenon Pharmaceuticals, Maintains $55 Price Target
RBC Capital Reiterates Outperform on Xenon Pharmaceuticals, Maintains $55 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
09:50
McKinsey states that by 2030, the talent gap in AI in China may reach 4 million.
09:46
Most of the Harbour Transportation stocks in Hong Kong fell, with COSCO Shipping Holdings (01919.HK) and COSCO SHIP ENGY (01138.HK) dropping over 4%, and OOIL (00316.HK), PACIFIC BASIN (02343.HK), and CHINA MER PORT (00144.HK) declining over 2%.
COSCO Shipping Holdings-3.26%
09:43
The USA Trade Representative Office (USTR) released the list of notorious markets for 2024, and Tencent WeChat has been removed from the list.
TENCENT+1.08%